Specificity of anti-human CD95 (APO-1/Fas) antibodies
The CD95 (APO-1/Fas) death receptor plays an important role in many physiological and pathophysiological systems. Thus, the CD95 system contributes to activation-induced cell death. Therefore, reliable antibodies recognizing human CD95 are of great interest. Detection of CD95 expression often relies...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
30 September 2002
|
| In: |
Biochemical and biophysical research communications
Year: 2002, Jahrgang: 297, Heft: 3, Pages: 459-462 |
| ISSN: | 1090-2104 |
| DOI: | 10.1016/S0006-291X(02)02242-8 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S0006-291X(02)02242-8 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0006291X02022428 
|
| Verfasserangaben: | Ingo Schmitz, Andreas Krueger, Sven Baumann, Sabine Kirchhoff, and Peter H Krammer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1754868169 | ||
| 003 | DE-627 | ||
| 005 | 20220819164243.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210414s2002 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0006-291X(02)02242-8 |2 doi | |
| 035 | |a (DE-627)1754868169 | ||
| 035 | |a (DE-599)KXP1754868169 | ||
| 035 | |a (OCoLC)1341404458 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schmitz, Ingo |d 1971- |e VerfasserIn |0 (DE-588)122317068 |0 (DE-627)705859169 |0 (DE-576)293216517 |4 aut | |
| 245 | 1 | 0 | |a Specificity of anti-human CD95 (APO-1/Fas) antibodies |c Ingo Schmitz, Andreas Krueger, Sven Baumann, Sabine Kirchhoff, and Peter H Krammer |
| 264 | 1 | |c 30 September 2002 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.04.2021 | ||
| 520 | |a The CD95 (APO-1/Fas) death receptor plays an important role in many physiological and pathophysiological systems. Thus, the CD95 system contributes to activation-induced cell death. Therefore, reliable antibodies recognizing human CD95 are of great interest. Detection of CD95 expression often relies on antibodies, e.g., suitable for Western blotting. To detect CD95, we compared the specificity of nine different anti-human CD95 antibodies recognizing different epitopes by using postnuclear supernatants of four different cell lines. Only two of the antibodies tested, both directed against intracellular epitopes of human CD95, detected endogenous human CD95 by Western blotting. Therefore, we conclude that results obtained with other anti-CD95 antibodies should be treated with caution. | ||
| 650 | 4 | |a Antibodies | |
| 650 | 4 | |a Apoptosis | |
| 650 | 4 | |a CD95/APO-1/Fas | |
| 650 | 4 | |a Western blot | |
| 700 | 1 | |a Krammer, Peter H. |d 1946- |e VerfasserIn |0 (DE-588)121766373 |0 (DE-627)081520255 |0 (DE-576)292873417 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biochemical and biophysical research communications |d [Amsterdam] : Elsevier B.V., 1959 |g 297(2002), 3, Seite 459-462 |h Online-Ressource |w (DE-627)254231691 |w (DE-600)1461396-7 |w (DE-576)103373039 |x 1090-2104 |7 nnas |a Specificity of anti-human CD95 (APO-1/Fas) antibodies |
| 773 | 1 | 8 | |g volume:297 |g year:2002 |g number:3 |g pages:459-462 |g extent:4 |a Specificity of anti-human CD95 (APO-1/Fas) antibodies |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0006-291X(02)02242-8 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0006291X02022428 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210414 | ||
| 993 | |a Article | ||
| 994 | |a 2002 | ||
| 998 | |g 121766373 |a Krammer, Peter H. |m 121766373:Krammer, Peter H. |d 50000 |e 50000PK121766373 |k 0/50000/ |p 5 |y j | ||
| 999 | |a KXP-PPN1754868169 |e 3909343589 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 14.04.2021"],"recId":"1754868169","language":["eng"],"title":[{"title_sort":"Specificity of anti-human CD95 (APO-1/Fas) antibodies","title":"Specificity of anti-human CD95 (APO-1/Fas) antibodies"}],"person":[{"given":"Ingo","family":"Schmitz","role":"aut","roleDisplay":"VerfasserIn","display":"Schmitz, Ingo"},{"given":"Peter H.","family":"Krammer","role":"aut","roleDisplay":"VerfasserIn","display":"Krammer, Peter H."}],"physDesc":[{"extent":"4 S."}],"relHost":[{"title":[{"title_sort":"Biochemical and biophysical research communications","subtitle":"BBRC","title":"Biochemical and biophysical research communications"}],"pubHistory":["1.1959 -"],"part":{"extent":"4","text":"297(2002), 3, Seite 459-462","volume":"297","pages":"459-462","issue":"3","year":"2002"},"titleAlt":[{"title":"BBRC"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Specificity of anti-human CD95 (APO-1/Fas) antibodiesBiochemical and biophysical research communications","note":["Gesehen am 14.06.2024"],"language":["eng"],"recId":"254231691","origin":[{"publisherPlace":"[Amsterdam] ; Orlando, Fla.","dateIssuedDisp":"1959-","dateIssuedKey":"1959","publisher":"Elsevier B.V. ; Academic Press"}],"id":{"zdb":["1461396-7"],"eki":["254231691"],"issn":["1090-2104"]},"physDesc":[{"extent":"Online-Ressource"}]}],"origin":[{"dateIssuedKey":"2002","dateIssuedDisp":"30 September 2002"}],"id":{"doi":["10.1016/S0006-291X(02)02242-8"],"eki":["1754868169"]},"name":{"displayForm":["Ingo Schmitz, Andreas Krueger, Sven Baumann, Sabine Kirchhoff, and Peter H Krammer"]}} | ||
| SRT | |a SCHMITZINGSPECIFICIT3020 | ||